DUBLIN--(BUSINESS WIRE)--The "Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User - Global Forecasts to 2024" report has been added to ResearchAndMarkets.com's offering.
The global next-generation sequencing market is projected to reach USD 16.35 billion by 2024 from USD 5.70 billion in 2018, at a CAGR of 19.2%.
Factors such as advancements in NGS platforms, declining NGS capital cost coupled with decreasing cost of sequencing, improving regulatory & reimbursement scenario for NGS-based diagnostic tests, initiatives from government & private bodies for large-scale sequencing projects, and increasing application of NGS in precision medicine & molecular diagnostics are expected to propel the growth of this market.
However, end-user budget constraints in developing nations are expected to restrain the growth of the next-generation sequencing market in the forecast period.
The next-generation sequencing market, by technology, is segmented into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and other sequencing technologies. The sequencing by synthesis segment is expected to command the largest share of the next-generation sequencing market in 2018.
The large share of this segment can be attributed to the continuous advancements in SBS technology-based consumables and NGS bioinformatics solutions as well as the launch of advanced cost- & time-efficient platforms based on SBS technology.
On the basis of end user, the next-generation sequencing market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. The hospitals & clinics segment is estimated to witness the highest growth rate during the forecast period.
The high growth in this segment can be attributed to the development of advanced NGS-based diagnostic solutions and growing number of agreements between companies and hospitals for developing advanced tests and products catering to the specific needs of hospitals and clinics.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Next-Generation Sequencing Market, By Product & Service
7 Next-Generation Sequencing Market, By Technology
8 Next-Generation Sequencing Market, By Application
9 Next-Generation Sequencing Market, By End User
10 Next-Generation Sequencing Market, By Region
11 Competitive Landscape
12 Company Profiles
- 10x Genomics
- Agilent Technologies, Inc.
- Beckman Coulter (A Subsidiary of Danaher)
- Becton, Dickinson and Company
- BGI
- Eurofins Scientific
- F. Hoffmann-La Roche AG
- Genewiz
- Illumina, Inc.
- Macrogen, Inc.
- Oxford Nanopore Technologies, Ltd.
- Pacific Biosciences of California, Inc.
- Perkinelmer, Inc.
- Qiagen N.V.
- Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/research/j8gs4g/nextgeneration?w=4
